Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul;49(7):1211-1221.
doi: 10.18502/ijph.v49i7.3574.

Factors Associated with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis

Affiliations
Review

Factors Associated with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis

Mojtaba Sepandi et al. Iran J Public Health. 2020 Jul.

Abstract

Background: The current study aimed to identify effective factors on the death among COVID-19 patients.

Methods: All articles published in the period Jan 1, 2020, to Mar 23, 2020, written in English and reporting factors associated with COVID-19 mortality were reviewed. The random-effects model with 95% CI was used to calculate the pooled Odds Ratio (OR) and Hazard Ratio (HR). Data were analyzed using Stata ver.11.0.

Results: The older age OR: 1.21(1.10-1.33) and male gender OR: 1.41(1.04-1.89) were most prone to death due to COVID-19. The Comorbidity with some chronic diseases such as Diabetes type2 OR: 2.42(1.06-5.52), Hypertension OR: 2.54(1.21-5.32), Kidney disorder OR: 2.61(1.22-5.60), Respiratory disorder 3.09 (1.39-6.88) and Heart diseases OR: 4.37 (1.13-16.90) can increase the risk of COVID19 mortality.

Conclusion: Infection with COVID-19 is associated with substantial mortality mainly in older patients with comorbidities. We found the significant effect of age, gender and comorbidities such as Diabetes Mellitus, Hypertension, Kidney disorders and Heart diseases on the risk of death in patients with COVID-19. The factors associated with mortality found in this research can help to recognize patients with COVID-19 who are at higher risk of a poor prognosis. Monitoring these factors can serve to give early warning for the appropriate interventions.

Keywords: COVID-19; Comorbidities; Coronavirus disease 2019; Mortality; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that there is no conflict of interest.

Figures

Fig.1:
Fig.1:
PRISMA Flow Diagram for included studies in current meta-analysis

References

    1. Alimohamadi Y, Taghdir M, Sepandi M. (2020). The Estimate of the Basic Reproduction Number for Novel Coronavirus disease (COVID-19): A Systematic Review and Meta-Analysis. J Prev Med Public Health, 53(3): 151–157. - PMC - PubMed
    1. Bonilla-Aldana DK, Dhama K, Rodriguez-Morales AJ.(2020). Revisiting the one health approach in the context of COVID-19: a look into the ecology of this emerging disease. Adv Anim Vet Sci, 8(3):234–7.
    1. Anderson RM, Heesterbeek H, Klinkenberg D, et al. (2020). How will country-based mitigation measures influence the course of the COVID-19 epidemic? Lancet, 395(10228):931–4 - PMC - PubMed
    1. Guo Y-R, Cao Q-D, Hong Z-S, et al. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Mil Med Res, 7(1):11. - PMC - PubMed
    1. Organization WH. (2020). Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available from: https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mis...

LinkOut - more resources